CRO

The Health-Care M&A Meter: Hot 2018 to Be Followed by Hotter 2019– The outlook for health-care mergers and acquisitions in 2019 suggests even more transactions this year as compared to 2018, with activity in the hospital and health system sector expected to continue, as well as increasing volume of deals in the physician services, home health. and health-care IT sectors.

Health-Care Info Tech Companies Make Moves in November– Health-care information technology companies stole the deal spotlight in November, setting up end-of-year numbers rivaling those of the long-term care, physician practice, and health and hospital system sectors.

Q4-2018 CRO Update – The Contract Research market continues to demonstrate substantial growth, in large part due to increasing demand for services in clinical trials between Phases II and IV, which account for the majority of the industry’s revenue. Private equity was the driving force behind much of the consolidation in 2018 and the fourth quarter was no different with two of the three transactions involving a private equity or PE-backed acquirer.

16th Annual Healthcare and Life Sciences Private Equity and Finance Conference – Kevin Palamara is attending the conference taking place February 20-21 in Chicago. He will also be participating in the panel discussion “Key Opportunities and Issues in Ophthalmology Investments.”

2019 Health Care Services Private Equity Symposium – Scott Davis will be attending the symposium taking place March 6-7 in Miami.

17th Annual Investment and M&A Opportunities in HEALTHCARE: Investing in the Middle-Market Healthcare Sector – Justin Hand is attending the conference taking place March 18-19 in Marina del Ray.

Big Health System Deals Dominate Transactions in October-The announced merger of two major Texas health systems is October’s deal-of-the-month.

What to Expect in a Due Diligence Process – Episode 7 of Provident’s Healthcare Dealcast

INSIGHT: Long-Term Care Consolidations Lead Third Quarter Health Transactions – The breakneck pace of healthcare transactions continued unabated in the third quarter.

What are the key financial factors to focus on when undergoing a process?– Episode 6 of Provident’s Healthcare Dealcast

Q3-2018 CRO Update – While the previous four quarters had been defined by super mergers and strategic consolidation, the third quarter of 2018 saw a resurgence of private equity investment into the contract research space.

Private Equity Investment in Health Care Stays Strong – Private equity investment is burgeoning throughout the U.S., and health care is one of the “in” targets for investors.

Health IT Sector Showing High Potential for Accelerated Growth – The health information technology sector is poised to become the next big thing for investors in the health-care industry. The physician practices sector experienced the second-highest growth in July, with an emphasis on certain medical practice areas.

INSIGHT: Strong Health-Care Deal Activity Seen in 2018’s First Half– The first half of 2018 saw a strong wave of M&A and deal making activity across nearly all sectors of the U.S. healthcare industry. The second half of 2018 likely will be just as robust.

What Types of Transactions Could be Right for my Healthcare Services Business?– Episode 3 of Provident’s Healthcare Dealcast

What are the Benefits of Hiring an Investment Banking Firm?– Episode 2 of Provident’s Healthcare Dealcast

Why Is Healthcare Consolidating?– Episode 1 of Provident’s Healthcare Dealcast

Q2-2018 CRO Update-The world’s three largest providers of contract research services (Quintiles, LabCorp, and PPD) control nearly 50% of the global revenue in the industry.

Q1-2018 CRO Update– Improving productivity and efficiency in clinical development processes will continue to be the main industry growth driver for 2018. As sponsors look to find ways to improve cycle time and reduce costs, contract research organizations that are able to provide risk based monitoring, adaptive trial designs, and flexible delivery models will see increased interest.

  • “Provident’s depth of experience and practical business savvy was demonstrated in their ability to cut through what sometimes looked like impasse.”

  • “We would not have been successful navigating the process without Provident’s hard work and active participation. They exceeded our expectations and we would highly recommend them to any health care company seeking a knowledgeable and engaged investment banking firm.”

  • “Provident listened to our story, confirmed that our business was valuable and made us feel like this was the only transaction important to them.”

  • “A lot of investment bankers were interviewed, Provident was chosen. Provident delivered. My clients could not be happier.”

  • “After working with Provident on several transactions, it is evident that their extensive industry knowledge and deal expertise prove to be invaluable to their clients.”

  • ”I have a tremendous amount of appreciation and gratitude to the Provident team for their hard work and diligence throughout this process. Each and every member of the Provident team is excellent at their jobs and it has been a pleasure working with such a professional team. Provident has provided outstanding guidance and counsel, and this deal could never have gotten done without Provident’s leadership.”

  • “While the decision to sell our business was a difficult one, Provident vigilantly represented and protected our best interests throughout the transaction.  Provident was the right choice for Cascade and I would recommend their services to anyone.”